60 Degrees Pharmaceuticals (SXTP) Other Operating Expenses (2022 - 2024)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Other Operating Expenses of $16623.0 for Q3 2024, up 123.58% year-over-year from $7434.9 in Q4 2023, and down 15.55% quarter-over-quarter from $19684.0 in Q2 2024.
60 Degrees Pharmaceuticals (SXTP) Other Operating Expenses (2022 - 2024) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Other Operating Expenses for 3 consecutive years, with $16623.0 the latest figure, recorded in Q3 2024.
- In Q3 2024, Other Operating Expenses rose 123.58% year-over-year to $16623.0; the TTM figure through Jun 2025 stood at $16623.0 (down 99.69% YoY), while the FY2024 annual figure was -$163228.0, down 103.03% from the prior year.
- Other Operating Expenses slipped to $16623.0 in Q3 2024 per SXTP's latest filing, from $19684.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $5.4 million in Q4 2023 and bottomed at -$70490.0 in Q3 2023.
- Historically, Other Operating Expenses has averaged $814617.6 across 3 years, with a median of $16623.0 in 2024.
- Annual changes were most pronounced in 2023 — Other Operating Expenses jumped 101.41% — and 2024, when it soared 2596.44%.
- 60 Degrees Pharmaceuticals' Other Operating Expenses stood at -$51714.0 in 2022, then jumped by 10635.71% to $5.4 million in 2023, then plunged by 99.69% to $16623.0 in 2024.
- Business Quant data shows SXTP's Other Operating Expenses at $16623.0 in Q3 2024, $19684.0 in Q2 2024, and $5.4 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | 60 Degrees Pharmaceuticals | 3.00 Mn | 1.98 Mn | 56,798.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 16,623.00 |
| Jun 30, 2024 | 19,684.00 |
| Dec 31, 2023 | 5.45 Mn |
| Sep 30, 2023 | -70,490.00 |
| Jun 30, 2023 | 730.00 |
| Mar 31, 2023 | 339,052.00 |
| Jun 30, 2022 | -51,714.00 |